Contraline, Inc.

Venture-backed company · Stage unknown· Charlottesville, VAcontraline.com

Biotechnology company pioneering reversible male contraception. Our products, Nes/T and ADAM, are daily and long-lasting options in clinical testing today.

Rounds on record
1
Latest round
May 29, 2026
Form D equity offering
Latest round size
$55.8M
Form D industry: Biotechnology
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

5 additional investors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. $55.8M
    sold on Form D

    Filed a Form D on 29 May 2026: $55.8M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactSEC Form DFor Investors, lenders, service providersFinancing history →
  2. 7 investors
    named

    7 investors on record;

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  3. 3 directors
    board

    3 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
7

Financing history

1 round
  1. May 29, 2026
    Form D equity offering · $55.8M (form d sold) · 77 investors
    Fact Form D · “Contraline, Inc. filed Form D: $55,804,741 sold of $115,929,658, Biotechnology”

Investors on record

8 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 8 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 8 listingseach firm's own card, as read

5 more listings counted above; the firms are named with a plan.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

1 officer, 3 directors

Timeline

1 event
  1. Jun 10, 2026
    Contraline, Inc. filed Form D: $55,804,741 sold of $115,929,658, Biotechnology
    Form D filed Fact Form D

Evidence

22 observations
Every observation on this company
  • Description: Sep 13, 2026 Fact
  • Entity type: Corporation Jun 10, 2026 Fact Form D
  • Form D industry group: Biotechnology Jun 10, 2026 Fact Form D
  • Amendment: false Jun 10, 2026 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jun 10, 2026 Fact Form D
  • Incorporated: overFiveYears Jun 10, 2026 Fact Form D
  • Investors named on site: 8 Sep 13, 2026 Fact
  • Jurisdiction: Delaware Jun 10, 2026 Fact Form D
  • Amount sold (Form D): $55.8M Jun 10, 2026 Fact Form D
  • Offering amount (Form D): $116M Jun 10, 2026 Fact Form D
  • Exemptions: 06b Jun 10, 2026 Fact Form D
  • First sale: 2026-05-29 Jun 10, 2026 Fact Form D
  • Investors (Form D): 77 Jun 10, 2026 Fact Form D
  • Minimum investment (Form D): 0 Jun 10, 2026 Fact Form D
  • Securities offered: equity Jun 10, 2026 Fact Form D
  • Office address: Jun 10, 2026 Fact Form D
  • Listed on portfolio page: Oct 1, 2026 Fact Firm website
  • Listed on portfolio page: Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Sep 15, 2026 Fact Firm website
  • Listed on portfolio page: Amboy Street Ventures, LLC Sep 13, 2026 Fact Firm website
  • Website status: ok Sep 13, 2026 Fact
  • Site title: Sep 13, 2026 Fact

Relationships across DFX

on 1 other DFX graph
Across the graphs

Contraline, Inc. is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

1 identity change, 2 dated events on the change ledger, latest event first
  • Event retracted
    2026-09-30
  • Portfolio entry removed
    2026-09-16source on record
  • Form D filed
    2026-06-10source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.